| COVID-19 |
1 |
1 |
| Monoclonal Antibody |
0 |
0.99 |
| Biologic Therapy |
0 |
0.52 |
| COVID-19 Vaccine |
0 |
0.52 |
| Immunocompromise |
0 |
0.95 |
| Severe Acute Respiratory Syndrome |
0 |
0.45 |
| Acute Respiratory Distress Syndrome |
0 |
0.36 |
| Vaccines |
0 |
0.2 |
| Chemotherapy |
0 |
0.15 |
| Child |
0 |
0.15 |
| Colorado |
0 |
0.15 |
| Immunization |
0 |
0.98 |
| Minnesota |
0 |
0.15 |
| Outpatient Clinic |
0 |
0.15 |
| Pharmacokinetics |
0 |
0.15 |
| Polymerase Chain Reaction |
0 |
0.15 |
| Prophylaxis |
0 |
0.15 |
| Spain |
0 |
0.15 |
| UK Site Content |
0 |
0.15 |
| Health Care Reform |
0 |
0.1 |